Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

AI helps cardiologists terminate AFib for good with ablation
Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care.
Same-day discharge after cardiac ablation: Cardiologists share recommendations
Same-day discharge won't always be a great fit after cardiac ablation, of course, but it has been associated with considerable patient satisfaction as well as improved efficiency and substantial cost savings. The Heart Rhythm Society and American College of Cardiology have shared a new scientific statement on the subject.
PFA startup founded by industry veteran to share first-in-human data at Heart Rhythm 2025
Field Medical, founded in 2022 by Steven Mickelsen, MD, is set to make a significant splash at the Heart Rhythm Society's annual meeting in San Diego. The company also just raised $40 million in financing.
Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns
The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system could result in serious injuries or death.
Underweight TAVR patients face higher mortality risk—obesity makes no significant impact
Reviewing data from more than 6,000 patients, researchers found little evidence of the "obesity paradox" observed elsewhere. Underweight TAVR patients, however, may face some significant long-term risks.

Higher mortality rates in women after PCI driven by noncardiac causes

The higher rates of all-cause mortality after percutaneous coronary intervention (PCI) observed in women can be attributed to noncardiac factors, suggests a single-center study published in Circulation: Cardiovascular Interventions.

Teaming Up to Treat Pulmonary Emboli: Clotbusters Illustrates Potential of Coordinated Response Programs

At one hospital, an aggressive treatment PE treatment program has dramatically reduced mortality.

Interventional Cardiology

AI helps cardiologists terminate AFib for good with ablation

Same-day discharge after cardiac ablation: Cardiologists share recommendations

PFA startup founded by industry veteran to share first-in-human data at Heart Rhythm 2025

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns

Underweight TAVR patients face higher mortality risk—obesity makes no significant impact